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Available online 12 December 2015A total of 272 methicillin-resistant Staphylococcus aureus (MRSA) from equine infections originating from 17
equine hospitals and 39 veterinary practices in Germany aswell as 67 isolates from personnel working at equine
clinics were subjected tomolecular typing. Themajority of isolates from horseswas attributed to clonal complex
(CC) 398 (82.7%). Within CC398, 66% of isolates belonged to a subpopulation (clade) of CC398, which is associated
with equine clinics.
MRSA attributed to CC8 (ST254, t009, t036, SCCmecIV; ST8, t064, SCCmecIV) were less frequent (16.5%). Single
isolates were attributed to ST1, CC22, ST130, and ST1660. The emergence of MRSA CC22 and ST130 in horses
was not reported so far. Nasal MRSA colonization was found in 19.5% of veterinary personnel with occupational
exposure to horses. The typing characteristics of these isolates corresponded to isolates from equine infections.
Comparing typing characteristics of equine isolates with those of a substantial number of isolates from human
infections typed at the German Reference Center for Staphylococci and Enterococci (2006–2014; n = 10864)
yielded that the proportion of isolates exhibiting characteristics of MRSA from equine medicine is very low
(b0.5%). As this low proportionwas also found amongMRSA originating fromnasal screenings of human carriers
not suffering from a staphylococcal infection (n = 5546) transmission of MRSA from equine clinics to the
community seems to be rare so far.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
MRSA
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Host speciﬁcity1. Introduction
Staphylococcus aureusbecomesmethicillin resistant by acquisition of
the mec genes (mecA and homologues) contained by staphylococcal
cassette chromosome mec (SCCmec) elements from which at least 11
basic types are known so far. S. aureus shows a rather clonal population
structure; typing of isolates by relevant methods reveals allocation to
certain clonal types, in particular multilocus-sequence typing (MLST)
and spa-typing are used as standard methodologies [1,2]. MRSA is
globally prevalent in nosocomial settings as hospital-associated MRSA
(HA-MRSA), which is mainly due to intra- and interhospital spread ofck@ukmuenster.de (R. Köck),
aus.de (W. Scheidemann),
edicine, University Hospital of
tal, Rahel Haus Str. 10,261330
. This is an open access article underepidemic clonal lineages [3–5]. In addition, MRSA emerged in the com-
munitywithout any relation to healthcare facilities (CA-MRSA, [6]). The
ﬁrst MRSA in animals was reported from cases of mastitis in dairy cattle
in 1972, followed by sporadic observations of infections in various ani-
mals including postsurgical wound infections in horses [7]. Since 2006
MRSA attributed to clonal complex CC398 received speciﬁc attention
since these so-called livestock-associated MRSA (LA-MRSA) is widely
disseminated among various livestock animalsmainly as an asymptom-
atic nasal colonizer [8,9]. Because of its capacity to cause a variety of
infections in humans such as skin and soft-tissue infections, surgical
wound and joint infections, invasive device infections (catheter,
endoprostheses), ventilator-associated pneumonia, and septicemia
[10–12] MRSA CC398 became a public health issue.
Furthermore, MRSA raised attention as nosocomial pathogens in
companion animals and equine medicine. For companion animals,
such as cats and dogs, clusters of MRSA infections in veterinary facilities
were observed [13–15]. Several studies have provided evidence of
hospital-associated (HA)-MRSA HA-MRSA transmission from humans
to small animals in veterinary facilities and vice versa. Molecular typingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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report of an outbreak of MRSA infections in horses in a veterinary hos-
pital came from the United States in 1999 [18], andwas followed by de-
scriptions of clusters of MRSA infections in equine hospitals in Canada
[19,20] and in Central Europe a few years later [21,22]. The majority of
the Canadian MRSA isolates from horses and staff, as reported by previ-
ous studies, has typically been identiﬁed as Canadian epidemicMRSA-5,
equivalent to “USA500”, a putatively equine clinic associated strain,
which accounted for nearly 10% of MRSA in Canadian hospitals by the
end of the 1990 [23]. It exhibits MLST ST8, spa type t064 (corresponds
to spa type 7 according to the Kreiswirth nomenclature), and contains
SCCmecIV [20]. This strain type was also reported for MRSA isolates
from horses from the United States and from Ireland [24,25]. In a
Canadian veterinary hospital a cluster of skin and soft tissue infections
in humans working there was also observed [26]. At this time the
central EuropeanMRSA isolates from nosocomial infections in horses ex-
hibited ST254, t036, and SCCmecIVh [21,22]. Meanwhile, MRSA CC398 is
prevalent as a nosocomial pathogen in veterinary clinics, particularly in
those for horses in Austria [22,27], Belgium [28,29], Germany [30], the
Netherlands [31], Switzerland [32], and the United Kingdom [17]. Fur-
thermore, nasal colonization of veterinary personnel attending horses
was reported [22,31–33]. The majority of MRSA CC398 isolates from
horse clinics exhibited a typical pattern of characteristics when subjected
to typing: spa type t011, more rarely t6867, SCCmecIVa, and phenotypic
resistance to gentamicin based on the aacA-aphD gene [22,31,32]. A
more detailed analysis of the population-structure throughmutation dis-
covery at 97 loci revealed that MRSA CC398 from horse clinics exhibiting
the abovementioned characteristics represent a particular subpopulation
(clade) of LA-MRSA CC398 [34].
The signiﬁcance of MRSA from colonization and infections in horses
for infections in humans has not been assessed in more detail so far.
Therefore, the objective of this study was to determine the proportion
of typical equineMRSA clones among theMRSA from human infections
based on a comparative analysis of typing characteristics.
2. Materials and methods
2.1. MRSA from infections in horses
The 272 isolates included originated from infections like soft-tissue
and joint infections, pneumonia, sinusitis, metritis, omphalophlebitis or
postoperative wound infections and were derived from horses treated
in 17 veterinary hospitals as well as in 39 large animal practices in
all regions of Germany (predominantly in the federal states of North
Rhine-Westphalia and Lower Saxony) between January 2011 and
February 2015.
2.2. MRSA from nasal swabs from veterinary personal and veterinarians
ttending horses
We prospectively collected nasal swabs of employees (veterinarians
and other staff; n = 349) in ﬁve equine clinics and three large practices
fromwhich also MRSA from infections in horses were derived between
2012 and 2015. This resulted in 67 MRSA isolates. Swabs were taken
from both nostrils and processed as described previously [35].
2.3. MRSA CC398 from different types of human infections
Isolates included in the analysis comprised (i) a sample of MRSA
isolates (n = 8912) which were sent to the German Reference Center
for Staphylococci and Enterococci between 2006 and 2013 for strain
characterization and typing in line with routine diagnostic procedures
or in case of outbreak investigations., and (ii) MRSA isolates from
blood cultures (n = 1952) which were prospectively (2011–2013)
collected in North Rhine-Westphalia and spa-typed [36].MRSA isolates from nasal swabs from humans: These isolates (n =
5546) originated from 150 different hospitals all over Germany. They
were collected both from patients with no staphylococcal infection at ad-
mission to hospitals and from inpatients between2006and2014and sent
to the German Reference Centre for Staphylococci and Enterococci for
molecular typing.
Primary diagnostics, species identiﬁcation of S. aureus, and further
characterization by means of spa-typing, attribution to clonal lineages
(complexes) and demonstration of mecA and of mecC as well as
phenotypic antibiotic susceptibility testing were performed as de-
scribed previously [35,37]. Minimum inhibitory concentrations (MICs)
were determined for 18 antibiotics belonging to 15 antibiotic classes
(including anti-staphylococcal β-lactams (penicillin, oxacillin), amino-
glycosides (gentamicin), macrolides (erythromycin), lincosamides
(clindamycin), tetracyclines (tetracycline), ﬂuoroquinolones (cipro-
ﬂoxacin, moxiﬂoxacin), phosphonic acids (fosfomycin), glycopeptides
(vancomycin,teicoplanin), oxazolidinones (linezolid), rifamycins
(rifampicin), steroid antibiotics (fusidic acid) lipopeptides (daptomycin),
glycylcyclines (tigecycline), pseudomonic acids (mupirocin), and
cotrimoxazol). SCCmec elements were characterized by using a PCR ap-
proach including a combination of different PCRs as described (www.
staphylococcus.net). PCR for luk-PV and for the genes of the immune
evasion cluster (IEC) was performed as described previously [38]. PCR
for IEC included int3 as a marker for integrase group 3 phages which
usually contain the IEC. MRSA CC398 disseminated in equine clinics can
be discriminated from LA-MRSA CC398 of other origin by means of a
canonical SNPs (canSNPs [34]). By aligning whole genome sequences of
three isolates of equine origin attributed to the equine clinic clade,
one isolate of porcine origin (http://www.digibib.tu-bs.de/?docid=
00058391) and 20 genomic sequences of isolates of different hosts attrib-
uted to CC398 published by Price et al. [39], we identiﬁed a further
canSNP in position 1837869 in SAPIG1748 (AM990992.1,[40]), which
can be easily identiﬁed by ordinary PCR and use of degenerated forward
primers (SNP at the very 3′end, degenerated nucleotide in the second
last position in bold): for the horse-speciﬁc clade of CC398, forward
primer 1748 h1 5′ATGCTTTTTGGCCAGCTIT, (canSNP1748T), and for the
general LA-MRSA CC398 subpopulation forward primer 1748u2 5′
ATGCTTTTTGGCCAGCTIG (canSNP1748G). As a reverse primer 1748r 5′
ATTACTCAAGGAACTGAA was used. PCR conditions (using PuReTaq
Ready-To-Go PCR Beads (GE Healthcare)) were: 95 °C5.00 [95 °C0.30;
45 °C30; 72 °C30]x35; 72 °C4.00. Correct ampliﬁcationwas conﬁrmed by se-
quencing of the amplicons for reference strains SO385 (LA-MRSA subpop-
ulation, [40]), and 71193 (human ancestral clade [41]), and 07-00334,
(equine clinic subpopulation [34]).
This PCR was validated by application to a set of 195 isolates
attributed to CC398 which was used for a phylogenetic analysis [34]. It
comprised of 195 isolates from different host species (horse n = 53,
human n= 80, pig n= 35, chicken n= 7, cattle n = 6, dog n= 5, tur-
key n= 4, goose n= 2, goat n= 1, cat n= 1, environment n= 1). PCR
for antibiotic resistance genes and PCR conditions were performed as
described previously [42]. For PCR detection of dfr genes we followed
the protocols according to McDougal et al. [43] for dfrA and to Argudin
et al. [44] for dfrG and dfrK.3. Results
3.1. MRSA isolates from horses
As shown in Table 1 the majority of MRSA isolates from horses was
attributed to CC398 (84.5%). Among the 135 isolates exhibiting spa
type t011 and gentamicin resistance, n = 127 contained SCCmecIV
and were attributed to the equine clinic speciﬁc clade by means of the
canSNP in ORF1748. The latter also applied to 40 isolates exhibiting
spa type t6867 and to isolates exhibiting the rare spa types t588, t779,
t1255, t4628, t4872, t10643 and t13788.
Table 1
Characteristics of MRSA from equine infections in Germany (n = 272).
Number of isolates (%) Typing characteristics Clonal complex Antibiotic resistance patterna Resistance genes
Spa-type SCCmec canSNP
123 (45.2%) t011 IV 1748T CC398 PEN, OXA, GEN, TET, CIP, MFL mecA, aacA-aphD, tet(M)a
4 (1.47%) IV CC398 PEN, OXA, GEN, TET, SXT, CIP, MFL mecA, aacA-aphD, tet(M)a,dfr(K)
1 (0.37%) t588 IV 1748T CC398 PEN,OXA,GEN,TET,CIP,MFL mecA, aacA-aphD, tet(M)
3 (1.1%) t779 IV 1748T CC398 PEN,OXA, GEN, TET, CIP, MFL mecA, aacA-aphD, tet(M)
2 (0.74%) t1255 IV 1748T CC398 PEN, OXA, GEN, TET, CIP mecA, aacA-aphD, tet(M)
1 (0.37%) t2576 IV 1748T CC398 PEN, OXA, GEN, ERY, CLI, TET, SXT mecA, aacA-aphD, ermA, tet(M),dfr(G)
1 (0.37%) t4628 IV 1748T CC398 PEN,OXA,GEN,TET,CIP,MFL mecA, aacA-aphD, tet(M)a
2 (0.74%) t4872 IV 1748T CC398 PEN, OXA, GEN, TET, CIP, MFL mecA, aacA-aphD, tet(M)a
4 (1.47%) t4872 IV 1748T CC398 PEN, OXA, GEN, ERY, CLI, TET, CIP, MFL mecA, aacA-aphD, tet(M)a, ermC
36 (13.1%) t6867 IV 1748T CC398 PEN, OXA, GEN, TET mecA, aacA-aphD, tet(M)a
2 (0.74%) t6867 IV 1748T CC398 PEN, OXA, GEN, TET, SXT mecA, aacA-aphD, tet(M)a,dfr(K)
2 (0.74%) t6867 IV 1748T CC398 PEN, OXA, GEN, TET, CIP, MFL mecA, aacA-aphD, tet(M)
1 (0.37%) t10643 IV 1748T CC398 PEN, OXA, GEN, TET, CIP, MFL mecA, aacA-aphD, tet(M)
1 (0.37%) t13788 IV 1748T CC398 PEN,OXA, GEN, TET, mecA, aacA-aphD, tet(M)
183 (66.5%) Subtotal MRSA CC98, SNP1748T
8 (2.9%) t011 V 1748G CC398 PEN, OXA, GEN, TET mecA, aacA-aphD, tet(M)a
1 (0.37%) t1451 V 1748G CC398 PEN, OXA, TET mecA, tet(M)
1 (0.74%) t779 II 1748G CC398 PEN,OXA,,ERY,CLI,TET, mecA, tet(M), ermC
21 (7.7%) t034 V 1748G CC398 PEN, OXA, ERY CLI, TET, CIP, MFL mecA, ermA, aacA-aphD, tet(M)
12 (4.4%) t034 V 1748G CC398 PEN, OXA, ERY CLI, TET, CIP, MFL mecA, ermC, aacA-aphD, tet(M)
1 (0.37%) t693 V 1748G CC398 PEN, OXA, TET mecA, tet(M)
1 (0.37%) t1292 IV CC22 PEN, OXA, ERY, CLI, CIP, MFL mecA, ermC
1 (0.37%) t747 IV CC22 PEN, OXA, ERY, CLI, CIP, MFL mecA, ermC
1 (0.37%) t549b ST1660c PEN, OXA, GEN mecA, aacA-aphD
1 (0.37%) t843 XI CC130 PEN, OXA mecC
1 (0.37%) t127 IV CC1 PEN, OXA mecA
28 (10.3%) t009 IV CC8 PEN, OXA, GEN, ERY, TET, CIP, MFL mecA, aacA-aphD, tet(M)
1 (0.37%) t036 IV CC8 PEN, OXA, GEN, ERY, CLI mecA, aacA-aphD, ermA
3 (1.1%) t064 IV CC8 PEN, OXA, GEN, ERY, CLI, TET, SXT mecA, aacA-aphD, ermC, tet(M),dfr(A)
3(1.1%) t064 IV CC8 PEN, OXA, GEN, TET, SXT, RAM mecA, aacA-aphD, tet(M),dfr(A)
5 (1.8%) t051 IV CC8 PEN, OXA, CIP, MFL mecA
272 (100%) Total
a PEN (penicillin G), OXA (oxacillin), GEN (gentamicin), TET (tetracycline), SXT (trimethoprim/sulfamethoxazole), CIP (ciproﬂoxacin), MFL (moxiﬂoxacin), ERY (erythromycin), CLI
(clindamycin), RAM (rifampicin). SNP1748T corresponds to the CC398 horse-clade speciﬁc SNP and SNP1748G corresponds to the CC398 general-clade speciﬁc SNP (see text for details).
b SCCmecwas untypeable for this isolate.
c No clonal complex deﬁned so far.
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of them contained SCCmecV. This also applied to 8 isolates which exhib-
ited spa type t011 and gentamicin resistance. One isolate exhibited spa
type 779 and contained SCCmecII. The second most frequent clonal
complex was CC8: 29 (11%) of the isolates were attributed to ST254
and 11 to ST8 (conﬁrmation byMLST); all of these CC8MRSA contained
SCCmecIV.
Other clonal complexes were more rarely represented by two
isolates attributed to CC22, one isolate to CC130 containing mecC, and
one isolate to CC1. One further isolate was attributed to ST1660.Table 2
Characteristics of MRSA from nasal colonization of veterinarians and veterinary personnel.
Veterinary hospitals and
veterinary practices
Proportion of
MRSA colonization
CC398
Equine clinic clade, SNP 1748T
spa t011, SCCmec
IV, GEN
spa t6867,
SCCmec IV, GEN
spa t462
SCCmec
Equine clinic A,2012/2013 3/31 (10%) 0 0 0
Equine clinic B,2013 I: 4/50 (8%) 2 1 0
2014 II: 23/63 (36.5%) 5 6 1
Equine clinic C,2013 I: 4/48 (4.3%) 2 1 0
2014 II: 7/20 (35%) 4 1 0
Equine clinic D,2012 4/18 (22%) 2 0 0
Equine clinic E,2014 8/37 (21.6%) 2 6 0
Veterinary practice A 1/12 (3.3%) 0 0 0
Veterinary practice B 8/50 (16%) 4 0 0
Veterinary practice C 5/20 (25%) 1 2 0
Total 67/349 (19.2%) 22 17 1
Legend: GEN, gentamicin resistance; SNP1748T corresponds to the CC398 horse-clade speciﬁ
details).The resistance proﬁles also are shown in Table 1. Gentamicin resis-
tance is strikingly frequent (85%) and mainly associated with isolates
of the equine clinic associated clade. The majority of the isolates from
horses were resistant to tetracycline (97.5 %) and to gentamicin
(85%). Resistance to ﬂuoroquinolones was found in 79% of the isolates
of the equine clinic associated clade and in 77.5% of all isolates from
horses. Furthermore, 15.6% were resistant to erythromycin, 14.7% to
cotrimoxazole, and 1.1% resistant to rifampicin. Resistance to other an-
tibiotics that are important for treatment of staphylococcal infections
such as glycopeptides, linezolid, daptomycin, tigecycline as well asCC8
Non equine clinic LA-MRSA CC398,
SNP 1748G
8,
IV, GEN
spa t7829,
SCCmecIV, GEN
spa t011,
SCCmecV
spa t034,
SCCmecV
spa t1255,
SCCmecV
t009 t036
0 0 0 0 3 0
0 0 1 0 0 0
1 7 2 1 0 0
0 0 1 0 0 0
0 1 1 0 0 0
0 0 0 0 0 2
0 0 0 0 0 0
0 1 0 0 0 0
0 1 3 0 0 0
0 1 1 0 0 0
1 11 9 1 3 2
c SNP and SNP1748G corresponds to the CC398 general-clade speciﬁc SNP (see text for
14 C. Cuny et al. / One Health 2 (2016) 11–17fusidic acid and fosfomycin was not observed. All of the isolates were
susceptible to mupirocin.
3.2. MRSA from nasal colonization of veterinary personnel and veterinarians
These data are shown in Table 2. Overall, 19.2% of 349 persons were
colonized with MRSA. The characteristics of these isolates largely
correspond to those from infections in horses.
3.3. MRSA isolates from infections humans
Among 10864 MRSA isolates from different types of infections in
humans 195 were attributed to CC398 based on spa-typing. Of these
158 isolates exhibited spa-types which have been observed in CC398
isolates from horses, (t011: n = 88; t034: n = 51, t6867: n = 6,
t1451: n = 5, t1255: n = 3, t2576: n = 3; t588: n = 1; t4628: n =
1). All of these 158 isolates were subjected to PCR for the can SNP in
SAPIG1748; 143 isolates were attributed to non-equine LA-MRSA
CC398, and 15 isolates were attributed to the equine clinic subpopula-
tion. Of the latter ones 4 originated from blood cultutres. The character-
istics of these isolates are shown in Table 3. The proportion of the equine
clinic subpopulation among all of the 10864 isolates from infections in
humans was 0.14%.
The characteristics of isolates attributed to CC8 exhibiting spa-types
t009 (corresponding to ST254) and t064 (corresponding to ST8) are also
shown in Table 1. Their proportion among all ofMRSA from infections in
humans was 0.07%.
Taken together MRSA with characteristics typical for horse clinics
represented 0.21% of all MRSA from humans included in this study.
At ﬁrst glance, the low proportion of MRSA CC398 attributed to the
equine clinic speciﬁc clade might be interpreted as low virulence for
humans. Therefore, we investigated the proportion of the equine clinic
speciﬁc clade among isolates obtained from nasal screenings. Among
5546 isolates merely 342 were attributed to CC398 (6.1%). From these
isolates 28 exhibited spa type t011 and resistance to gentamicin and
only two of these isolates contained SCCmecIV and canSNP1748T.
Furthermore, four isolates exhibited spa type t6867, contained
SCCmecIV and canSNP1748T. This resulted in a proportion of 0.1% of
the equine clinic associated clade among the 5546 isolates. There was
only one isolate exhibiting spa type t009 and one further exhibiting
spa type t064.
3.4. Demonstration of the immune evasion gene cluster (IEC) in isolates of
horse and human origin attributed to CC8 and exhibiting the same spa-types
S. aureus of animal origin usually lacks the immune evasion gene
cluster IEC [8,45]. It is contained by prophages of the int3 group and
consists of an enterotoxin gene (sea or sep) and the basic immuneTable 3
Proportion of MRSA from infections in humans (n = 10,864) which were attributed to CC398
infections in horses.
Typing characteristics Clonal complex Antibiotic resistance pattern
spa-type SCCmec canSNP
t011 IV 1748T CC398 PEN, OXA, GEN, TET
t588 IV 1748T CC398 PEN, OXA, GEN, TET, CIP, MFL
t1255 IV 1748T CC398 PEN, OXA, GEN, TET,CIP,MFL
t4628 IV 1748T CC398 PEN, OXA, GEN, ERY, CLI, TET
t6867 IV 1748T CC398 PEN,OXA,GEN,TET
Subtotal CC398
t009 CC8 (ST254) PEN, OXA, GEN, ERY, CLI, TET, C
t064 CC8 (ST8) PEN, OXA, GEN, TET, CIP, SXT
Subtotal other CC
Total
PEN (penicillin G), OXA (oxacillin), GEN (gentamicin), TET (tetracycline), SXT (trimethopri
(clindamycin), DAP (daptomycin).evasion genes sak (staphylokinase), scn (staphylococcal complement
inhibitory protein), and chp (chemotaxis inhibitory protein). Among
isolates fromhorses attributed to CC398 (spa type t011), exhibiting gen-
tamicin resistance and containing SCCmecIV, 10% of the isolates
contained the IEC [38]. The isolates from infections in humans reported
here,whichwere attributed to thehorse-speciﬁc cladewere all negative
for the IEC. As shown in Table 4 isolates with spa type t009 from horses
and fromnasal swabs of veterinary personnel and veterinarians lack the
IEC, whereas the two isolates from infections in humans contained it.
Among isolates exhibiting spa type t064, IEC with the same pattern of
immune evasion genes is contained by isolates of both horse and
human origin.
4. Discussion
The data reported in this study conﬁrm that MRSA CC398 has
become themost frequentMRSA in veterinary hospitals caring for hors-
es in Germany [30]. Based on a substantial number of isolateswe specify
that the majority of them were attributed to the equine clinic speciﬁc
clade of MRSA CC398. Isolates exhibiting t011 are still prevalent
among the equine clinic associated clade, this spa typewas also exhibit-
ed by the early isolates of this clade as reported previously [34]. It is very
likely that spa types t588, t779, t1255, t1451, t4628, and t4872 derived
from spa type t011, because they differ by one genetic event (deletion of
one repeat or one point mutation in a repeat) only (www.ridom.com).
Also isolates exhibiting spa type t6867, which differs from t011 by sev-
eral genetic events, evolved from isolates exhibiting t011 [34]. They rep-
resent the second most frequent spa type among isolates attributed to
the equine clinic speciﬁc clade. A high prevalence of MRSA CC398,
t6867 was also reported by a recent survey on MRSA among horses in
Germany [30]. We also observed MRSA CC398 with spa types t011
and t034 which were not attributed to the equine clinic speciﬁc clade
among both isolates from infections in horses and from colonization of
veterinary personnel. These spa types are particularly frequent among
MRSA CC398 from livestock. We hypothesize that the horses acquired
them from veterinarians also attending livestock or via environmental
transmission. The ﬁnding of isolates not attributed to the equine clinic
associated LA-MRSA and exhibiting both spa type t011 and resistance
to gentamicin underlines that spa typing for the epidemiological analy-
sis of MRSA infections in horses has to be supplemented by additional
genomic markers.
Among all horse isolates about 15% were attributed to CC8 and 13%
exhibited spa types that were already described for MRSA from horse
clinics in Northern America and in Europe such as t064, t036 and t009
[14,22,46]. MRSAwith spa type t051, SCCmecIV have not been reported
fromhorses so far and the isolate detected in our studywas attributed to
ST8 by MLST. This is in contrast to MRSA t051 of human origin which is
usually attributed to ST247 and contains SCCmecI [3–5]. Spa-type t051and CC8 exhibited typing characteristics as MRSA which were typically associated with
Relevant resistance genes Number of isolates Proportion
mecA, aacA-aphD, tet(M) 5 0.046%
mecA, aacA-aphD, tet(M) 1 0.009%
mecA, aacA-aphD, tet(M) 2 0.018%
mecA, aacA-aphD, tet(M), erm(C) 1 0.009%
mecA, aacA-aphD, tet(M) 6 0.055%
15 0.137%
IP, MFL mecA, aacA-aphD, erm(A), tet(M) 2 0.018%
mecA, aacA-aphD, erm(C), tet(M), dfr(A) 6 0.055%
8 0.074%
23 0.212%
m/sulfamethoxazole), CIP (ciproﬂoxacin), MFL(moxiﬂoxacin), ERY (erythromycin), CLI
Table 4
Occurrence of the immune evasion gene cluster inMRSA isolates attributed to clonal com-
plex CC8 from horses and humans.
Origin Number
of isolates
Spa-type PCR for
int3
PCR demonstration of
IEC genes
sea sep sak chp scn
Infection in horses 28 t009 − − − − − −
6 t064 + + − + + +
Nasal colonization of
veterinarians
and other personnel
3 t009 − − − − − −
Infections in humans 1 t009 + + − + + +
1 t009 + + − + − +
6 t064 + + − + − +
IEC = immune evasion cluster.
15C. Cuny et al. / One Health 2 (2016) 11–17differs from t008 which is most frequent among isolates attributed to
ST8 by deletion of only one repeat (www.ridom.com).
The results of our study indicate that spread of MRSA from equine
clinics to the community is rare so far. Twomain routes of MRSA spread
from veterinary hospitals into the human community are possible:
(i) Colonization of veterinarians. Indeed, earlier studies observed that
the prevalence of MRSA colonization in families of livestock veterinar-
ians was 9.5% [35]. (ii) Transmission of MRSA from animals that are
still positive when discharged from the hospital to their caretakers “at
home” and further dissemination from thereon in human and animal
populations as suggested by an observation in Belgium [33].
Frequencies of colonization of humans with occupational exposure
in horse clinics in outbreak situations reported by other studies were
13.7% for an Austrian university veterinary hospital [22], 9.4% for a
Dutch veterinary hospital [31] and up to 22.2% for a Swiss university
veterinary hospital [32]. According to our recent data nasal colonization
of humans in veterinary hospitals attending horses is still high and
above the proportion reported for veterinarians and veterinary person-
nel in general [47,48] besides livestock veterinarians [35]. The typing
characteristics of the isolates from veterinarians in this studymostly re-
ﬂect the clonal lineages of MRSA from equine infections. Of particular
interest is the demonstration of LA-MRSA CC398 not attributed to the
equine clinic speciﬁc clade, which might have been acquired by the
veterinarians whilst working with livestock animals. The capacity of
LA-MRSA CC398 for causing infections in humans is well documented
(for summary see [10–12]). Although the proportion of LA-MRSA
among all MRSA from infections in humans is comparatively low in
Germany [10,11,49], it amounts up to 14% in hospitals which are located
in German geographical areas with a high density of conventional ani-
mal farming facilities [11]. As reported here, the proportion of MRSA at-
tributed to the equine clinic speciﬁc subpopulation of MRSA CC398
among all MRSA from infections in humans seems to be very low so
far. We hypothesize that this is rather due to limited dissemination be-
yond humans exposed to horses with MRSA colonization and/or infec-
tions than to low virulence for humans. This is also suggested by
ﬁnding isolates attributed to the equine clinic speciﬁc clade among
blood culture isolates. Among the MRSA from nasal swabs taken at
admission to hospitals from asymptomatic carriers we found the same
low proportion. It remains to be shown whether the equine clinic
speciﬁc clade of CC398 has a lower virulence potential for humans
than MRSA CC398 from livestock. MRSA attributed to CC8 and
exhibiting gentamicin resistance and spa type t009 or t064 were very
rare among MRSA isolates from infections in humans in Germany.
MRSA from horses with spa type t009 lacked the immune evasion
gene cluster as previously shown [14]. We found the same for isolates
from nasal colonization of veterinarians. Isolates from infections in
humans, however, contained it.
MRSA with spa type t009 were widely disseminated in Northern
German hospitals in the 1990s (“Hannover area epidemic MRSA” [5])
and became rare thenceforth. Thus, MRSA with spa type t009 frominfections in humans are very likely remainders of this previously
epidemic HA-MRSA. We should, however, be careful with deducing re-
cent mutual exchange between human and veterinary hospitals simply
from the presence of the IEC in horse isolates. We found IEC also in an
MRSA isolate ST8, SCCmecIV, t064 that originated from an Austrian vet-
erinarian hospital in 2007. Low proportions of MRSA CC8, spa type t064,
SCCmecIV among all MRSA from infections in humanswas also reported
from a medical center in Chicago (0.7% [50]), whereas it was slightly
higher among sporadic MRSA isolates from Ireland (2 %, [51]) and
amounted to 6% among isolates from three hospitals in New York [52].
Fortunately, there are only a few published reports on infections with
equine MRSA clones in veterinarians and veterinary personnel so far
such as on a cluster of infections with MRSA CC8, spa type t064,
SCCmecIV in Canada [20].
A few equine isolates (1.85%) were attributed to clonal lineages ST1,
ST22, ST130 and ST1660. MRSA ST1, spa type t127 were already reported
from equine infections in Austria in 2007 [22] where they are still
observed [27]. They were rare in Germany among CA-MRSA, which
contain luk-PV [42]. In Romania however, MRSA ST1 is prevalent among
the MRSA from nosocomial infections in humans [53]. The occurrence of
MRSA isolates with spa types associated with ST22 recently increased
among MRSA from nosocomial infections making ST22 the most
expandingMRSA clone in Europe [54]. MRSA attributed to CC130, usually
containing mecC, are widely disseminated among animals, in particular
ruminants [55]. In this study, we report the ﬁrst infection with MRSA
CC130 containing mecC in a horse. For MRSA CC130 from infections in
humans a zoonotic origin is rather likely [56]. They are, however, rare
among the MRSA from human infections in Germany [37]. It seems that
MRSA belonging to ST1660 are also speciﬁc for equine clinics. They
were already reported from a Swiss horse hospital [32] and putatively
represent a horse associated strain. However, this clonal lineage is not dis-
seminated in other animals or prevalent among infections in humans.
Finally, the high proportion of isolates that were resistant to
ﬂuoroquinolones requires speciﬁc attention. Resistance to these antibi-
otics was obviously infrequent or absent among isolates from earlier
studies in Europe [22,32,29] and Canada [20]. Its rise during the last
years probably reﬂects selective pressure by use of ﬂuoroquinolones
in equine clinics. For dissemination of MRSA in medical hospitals use
of ciproﬂoxacin is known as risk factor for dissemination of epidemic
HA-MRSA resistant to these antibiotic [56].
Taken together, MRSA from infections in horses mostly seem not to
spread beyond equinemedicine and therefore are rare among theMRSA
from infections in humans. However, as MRSA from infections in
humans in Germany are not notiﬁable besides those of the bloodstream
and central nervous system, we cannot exclude the possibility of infec-
tions in humans with occupational or other contacts to horses with
MRSA colonization and infections. In case of infections there are still suf-
ﬁcient alternatives for antibiotic treatment.
5. Conclusions
This study shows that MRSA infections in horse clinics are a nosoco-
mial problem and that there is mutual transmission between humans
and horses. Therefore surveillance at the interface of human and
veterinary medicine is warranted. This should also pay attention to
the apparent international dissemination of different clonal lineages of
MRSA in horses and to the emergence of human hospital-associated ep-
idemic MRSA in equine clinics. There is an urgent need for establishing
and implementing guidelines on the prevention and control of MRSA
spread among horses.
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